Italian Sarcoma Group

4 trials 3 recruiting Academic / non-commercial

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

1 Completed trials

2 Countries active

5 Unique IMPs

100% Results reported

Phase II

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Desmoplastic small round cell tumour 1 Solitary fibrous tumour 1 Leiomyosarcoma metastatic 1 Leiomyosarcoma 1

Top IMPs

TRABECTEDIN 2 ERIBULIN 1 GEMCITABINE 1 IRINOTECAN HYDROCHLORIDE TRIHYDRATE 1 LURBINECTEDIN 1

All trials

4 total

Phase II study of lurbinectedin and irinotecan in adult and young adult patients with advanced desmoplastic small round cell tumor (DSRCT) Recruiting

2024-519261-21-00 Phase II 2 countries IRINOTECAN HYDROCHLORIDE TRIHYDRATE; LURBINECTEDIN
A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally adva… Recruiting

2024-513820-40-00 Phase II 1 country GEMCITABINE; TRABECTEDIN
Phase II study on trabectedin in adults and young adults HEY1-NOCA2 positive skeletal and extra-skeletal mesenchymal chondrosarcoma (MCS) Recruiting

2024-514319-85-00 Phase II 1 country TRABECTEDIN
ERibulin in Advanced Solitary fibrous tumor, an ItaliaN sarcoma Group phase II study (ERASING) Ended

2024-517795-38-00 Phase II 1 country ERIBULIN

Showing 1–4 of 4 trials

← All sponsors A–Z